INVIVO HEMATOPOIETIC EFFECTS OF RECOMBINANT INTERLEUKIN-1-ALPHA IN MICE - STIMULATION OF GRANULOCYTIC, MONOCYTIC, MEGAKARYOCYTIC, AND EARLY ERYTHROID PROGENITORS, SUPPRESSION OF LATE-STAGE ERYTHROPOIESIS, AND REVERSAL OF ERYTHROID SUPPRESSION WITH ERYTHROPOIETIN
Authors:
- DJ KECKLERDKDJ KECKLER
- MI TOPPERMTMI TOPPER
- PG BRAUNSCHWEIGERPBPG BRAUNSCHWEIGER
- P FURMANSKIPFP FURMANSKI
- 15 February 1989
- journal article
- research article
- Vol. 73 (3) , 678-683
Abstract
Interleukin-1.alpha.(IL-1.alpha.) is a macrophage-derived, multifunctional cytokine that broadly potentiates myelopoiesis and induces the synthesis of hematopoietic colony-stimulating factors(CSF) in vitro and in vivo. To evaluate the possibility for use in IL-1.alpha. in ameliorating in vivo bone marrow suppression induced by drugs or radiation, we examined the in vivo effects of the cytokine or erythropoietic and other hematopoietic progenitor cells. Normal mice were treated with a single intraperitoneal (IP) injection of recombinant human IL-1.alpha. at varying doses and were assayed at various times post-treatment. By six hours postinjection, a significant suppression of mature erythroid progenitors (CFU-E) was observed in animals treated with IL-1.alpha. (0.5 .mu.g/mouse), with maximum suppresssion of CFU-E and peripheral blood reticulocyte counts occurring at 24 hours. Decreases in peripheral blood hematocrit did not occur after a single IL-1.alpha. injection but were observed after multiple injections of the cytokine. The suppressive effects of IL-1.alpha. on late-stage erythropoiesis were abrogated by simultaneous administration of erythropoietin (EPO). At 48 hours post-treatment, a marked stimulation was observed in the numbers of spleen and marrow immature erythroid (BFU-E), macrophage (CFU-M), granulocyte (CFU-G), granulocyte-macrophage (CFU-GM), and megakaryocyte (CFU-meg) progenitor cells. These results demonstrate the potential use of IL-1.alpha. as a generalized stimulator of hematopoiesis and show that the cytokine-induced suppression of late-stage erythropoiesis can be prevented by EPO.Keywords
This publication has 25 references indexed in Scilit:
- Interleukin 1 is a radioprotector.The Journal of Immunology, 1986
- Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted ratsPhysiology & Behavior, 1985
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.Journal of Experimental Medicine, 1985
- Studies of interferon as a regulator of hematopoietic cell proliferation.The Journal of Immunology, 1985
- Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAsNature, 1985
- Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.Journal of Experimental Medicine, 1983
- ERYTHROPOIETIN PRODUCTION IN FASTED RATS - EFFECTS OF THYROID-HORMONES AND GLUCOSE SUPPLEMENTATION1981
- INVITRO INTERACTIONS OF PGE AND CAMP WITH MURINE AND HUMAN ERYTHROID PRECURSORS1980
- Infection of macrophages with friend virus: Relationship to the spontaneous regression of viral erythroleukemiaCell, 1979
- Production by spleen and lymph node cells of conditioned medium with erythroid and other hemopoietic colony‐stimulating activityJournal of Cellular Physiology, 1978